77 related articles for article (PubMed ID: 6278144)
21. Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells.
Dave VP; Allan JE; Slobod KS; Smith FS; Ryan KW; Takimoto T; Power UF; Portner A; Hurwitz JL
Virology; 1994 Mar; 199(2):376-83. PubMed ID: 7510085
[TBL] [Abstract][Full Text] [Related]
22. [Serological survey of para-influenza 3 virus in cattle in the Province of Valdivia].
Reinhardt G; Polette M; Cano M
Zentralbl Veterinarmed B; 1980; 27(2):144-8. PubMed ID: 6258358
[No Abstract] [Full Text] [Related]
23. Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination.
Chen Y; Webster RG; Woodland DL
J Immunol; 1998 Mar; 160(5):2425-32. PubMed ID: 9498786
[TBL] [Abstract][Full Text] [Related]
24. Skin hypersensitivity to parainfluenza-3 virus in cattle. II. Induction by vaccination and specificity.
Moreno-López J; Törnqvist M; Möllerberg L; Morein B
Zentralbl Veterinarmed B; 1976 Dec; 23(10):801-8. PubMed ID: 65073
[No Abstract] [Full Text] [Related]
25. Distribution of macrophage cytotoxic and macrophage helper functions on BSA discontinuous gradients.
Chapes SK; Tompkins WA
J Reticuloendothel Soc; 1981 Dec; 30(6):517-30. PubMed ID: 6978939
[No Abstract] [Full Text] [Related]
26. Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes.
Skiadopoulos MH; Surman SR; Durbin AP; Collins PL; Murphy BR
Virology; 2000 Jun; 272(1):225-34. PubMed ID: 10873765
[TBL] [Abstract][Full Text] [Related]
27. Characterization of parainfluenza type 3 virus isolated from the lung of a lamb with pneumonia.
Lehmkuhl HD; Cutlip RC
Am J Vet Res; 1982 Apr; 43(4):626-8. PubMed ID: 6280532
[TBL] [Abstract][Full Text] [Related]
28. Differences in lymphocyte responsiveness to lymphokines in two inbred strains of Syrian hamster.
Wright KE; Clark DA; Rawls WE
J Immunol; 1984 Jul; 133(1):286-92. PubMed ID: 6609982
[TBL] [Abstract][Full Text] [Related]
29. A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge.
Greer CE; Zhou F; Legg HS; Tang Z; Perri S; Sloan BA; Megede JZ; Uematsu Y; Vajdy M; Polo JM
Vaccine; 2007 Jan; 25(3):481-9. PubMed ID: 17052811
[TBL] [Abstract][Full Text] [Related]
30. Persistence of antibodies and anamnestic response in calves vaccinated with inactivated infectious bovine rhinotracheitis virus and parainfluenza-3 virus vaccines.
Sweat RL
J Am Vet Med Assoc; 1983 Apr; 182(8):809-11. PubMed ID: 6303996
[TBL] [Abstract][Full Text] [Related]
31. Hamster T cells participate in MHC alloimmune reactions but do not effect virus-induced cytotoxic activity.
Nelles MJ; Streilein JW
Immunogenetics; 1980 Jul; 11(1):75-86. PubMed ID: 6449478
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to human T lymphocytes in xenoantisera elicited with a new immature T-cell line (Peer).
Schlesinger M; Rabinowitz R; Kertes T; Ravid Z; Goldblum N
Thymus; 1981 Feb; 2(4-5):235-43. PubMed ID: 7015584
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal analysis of the acute Sendai virus-specific CD4+ T cell response and memory.
Topham DJ; Doherty PC
J Immunol; 1998 Nov; 161(9):4530-5. PubMed ID: 9794378
[TBL] [Abstract][Full Text] [Related]
34. Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants.
Lee MS; Greenberg DP; Yeh SH; Yogev R; Reisinger KS; Ward JI; Blatter MM; Cho I; Holmes SJ; Cordova JM; August MJ; Chen W; Mehta HB; Coelingh KL; Mendelman PM
J Infect Dis; 2001 Oct; 184(7):909-13. PubMed ID: 11509996
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
36. Production of cytotoxic factor in the spleen of dengue virus-infected mice.
Chaturvedi UC; Bhargava A; Mathur A
Immunology; 1980 Aug; 40(4):665-71. PubMed ID: 6968713
[TBL] [Abstract][Full Text] [Related]
37. [Immunofluorescence with virus PI-3--immunofluorescent findings on calf kidney cell cultures infected with different doses and strains of the virus].
Zuffa A; Chumchal R
Vet Med (Praha); 1978 Apr; 23(4):193-204. PubMed ID: 208218
[No Abstract] [Full Text] [Related]
38. Immunogenicity of inactivated vaccines prepared with parainfluenza viruses type 1 and type 3, administered experimentally by nasal or oral route.
Petrescu AL; Petica M; Bârnaure F; Athanasiu P
Rom J Virol; 1998; 49(1-4):97-115. PubMed ID: 10892431
[TBL] [Abstract][Full Text] [Related]
39. A terminal labelling assay using 3H-uridine to measure cell-mediated cytotoxic responses against parainfluenza type 3 infected target cells.
Williamson SI; Gibbins BL
J Virol Methods; 1981 Mar; 2(4):237-47. PubMed ID: 6262347
[TBL] [Abstract][Full Text] [Related]
40. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
Nash AA; Ashford NP
Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
